Kuros Biosciences AG (FRA:YTSN)

Market Cap	933.20M +21.5%
Revenue (ttm)	124.40M +71.5%
Net Income	2.17M
EPS	0.05
Shares Out	n/a
PE Ratio	429.51
Forward PE	86.37
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	12
Open	23.98
Previous Close	23.98
Day's Range	23.98 - 23.98
52-Week Range	23.32 - 35.32
Beta	n/a
RSI	35.93
Earnings Date	Mar 10, 2026

About Kuros Biosciences AG

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bon...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2016
• Employees: 178
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: YTSN

Financial Performance

Financial numbers in USD